$46.8B Roche, Genentech Deal Ends Shareholder Suit
Stuart Grant, managing director at Grant & Eisenhofer PA, said the settlement would include not only an increased share price, but also protections on the back end for shareholders who chose not to tender.
Court papers describing the deal in detail have not yet...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login